)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
Evofem Biosciences (EVFM) investor relations material
Evofem Biosciences Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary14 Aug, 2025
Executive summary
Net product sales for Q2 2025 increased 16% year-over-year to $4.8 million, driven by the addition of SOLOSEC and higher PHEXXI pricing, despite lower PHEXXI volume overall.
The company continues to focus on commercializing PHEXXI and SOLOSEC, expanding global reach through licensing agreements, and maintaining a lean operating structure.
Management highlights substantial doubt about the company's ability to continue as a going concern due to insufficient liquidity and significant working capital deficit.
Strategic cost reductions and global expansion initiatives advanced, including UAE submissions for PHEXXI and SOLOSEC.
Special Meeting of Stockholders planned to approve merger with Aditxt, making the company a wholly owned subsidiary.
Financial highlights
Q2 2025 net product sales were $4.8 million, up 16% from $4.2 million in Q2 2024; six-month sales were $5.7 million, down 27% year-over-year due to lower PHEXXI volume.
Q2 2025 net loss attributable to common stockholders was $1.8 million, compared to net income of $1.3 million in Q2 2024.
Operating expenses in Q2 2025 rose to $6.1 million from $5.5 million year-over-year, mainly due to higher R&D and selling/marketing costs.
Cash and cash equivalents at June 30, 2025 were $0.7 million, all restricted; working capital deficit stood at $64.9 million.
$2.4 million raised in Q2 2025 from sale of senior subordinated notes and warrants to Aditxt.
Outlook and guidance
Management expects to continue incurring net losses and negative cash flows for the foreseeable future.
Plans to meet cash needs include generating revenue from PHEXXI and SOLOSEC, restructuring payables, and seeking additional funding or partnerships.
If unable to secure funding or increase revenue, the company may need to reduce spending, extend payment terms, liquidate assets, or cease operations.
Anticipates increased PHEXXI awareness and sales in Q3 2025 and beyond, driven by social media and press coverage.
Merger with Aditxt subject to stockholder approval and Aditxt securing $15 million to satisfy senior secured noteholder.
Explain Evofem's cost reduction strategies.
Assess impact of social media on PHEXXI sales.
What are the key conditions for Aditxt merger?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Evofem Biosciences earnings date
Q3 202513 Nov, 2025
Next Evofem Biosciences earnings date
Q3 202513 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
)
Edge19 Sep 2025
American Express: An Empire of Plastic
How history, brand, and structure have steadily built American Express' moat, and why Warren Buffett still calls it a one-of-a-kind business.
Frequently asked questions
Evofem Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes women's sexual and reproductive health products.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage